lotilibcin: isolated from Staphylococcus aureus; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 16184172 |
| CHEMBL ID | 4788902 |
| MeSH ID | M0578263 |
| Synonym |
|---|
| wap-8294a2 |
| lotilibcin [inn] |
| 169148-84-9 |
| lotilibcin |
| xt4808181k , |
| unii-xt4808181k |
| wap 8294a2 |
| lotilibcin [who-dd] |
| DTXSID50583257 |
| pubchem_16184172 |
| CHEMBL4788902 |
| Q27293985 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1724005 | Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI M07-A8 protocol based microdilution method | 2020 | Bioorganic & medicinal chemistry, 09-15, Volume: 28, Issue:18 | Total synthesis and a systematic structure-activity relationship study of WAP-8294A2. |
| AID1724006 | Antibacterial activity against methicillin-resistant Staphylococcus aureus SA86 by CLSI M07-A8 protocol based microdilution method | 2020 | Bioorganic & medicinal chemistry, 09-15, Volume: 28, Issue:18 | Total synthesis and a systematic structure-activity relationship study of WAP-8294A2. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (18.25) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 12 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||